BioLineRx Readies Phase 3 Myeloma Trial to Mobilize Stem Cells for Transplant – Myeloma Research News
Myeloma Research News |
BioLineRx Readies Phase 3 Myeloma Trial to Mobilize Stem Cells for Transplant
Myeloma Research News BioLineRx has launched a Phase 3 trial to assess if adding BL-8040 to standard treatment will improve the outflux of blood stem cells from bone marrow before a stem cell transplant in multiple myeloma. “I am very excited to test the role of BL-8040, a … |
